We are live on ! Find out more
ARIA

Ariad Pharmaceuticals Inc
ARIA

Delisted

ARIA was delisted on the 15th of February, 2017.

Back to rankings

198 hedge funds and large institutions have $2.69B invested in Ariad Pharmaceuticals Inc in 2013 Q2 according to their latest regulatory filings, with 198 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

1% more call options, than puts

Call options by funds: $16M | Put options by funds: $15.8M

Holders
198
Holders Change
+198
Holders Change %
–
% of All Funds
6.46%
Holding in Top 10
5
Holding in Top 10 Change
+5
Holding in Top 10 Change %
% of All Funds
0.16%
New
198
Increased
–
Reduced
–
Closed
–
Calls
$16M
Puts
$15.8M
Net Calls
+$187K
Net Calls Change
+$187K

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
BBA
26
Baker Bros. Advisors
New York
$25.4M +$25.7M +1,450,000 New
CCM
27
Consonance Capital Management
New York
$23.3M +$23.6M +1,331,100 New
TCIM
28
TIAA CREF Investment Management
New York
$23.1M +$23.4M +1,319,435 New
UBS AM
29
UBS AM
Illinois
$22.9M +$23.2M +1,310,737 New
RG
30
Redmile Group
California
$22.3M +$22.6M +1,277,109 New
T. Rowe Price Associates
31
T. Rowe Price Associates
Maryland
$22.3M +$22.6M +1,275,250 New
DM
32
Deerfield Management
New York
$22.1M +$22.4M +1,265,104 New
Deutsche Bank
33
Deutsche Bank
Germany
$20.8M +$21.1M +1,189,067 New
O
34
OppenheimerFunds
New York
$17.5M +$17.7M +1,000,000 New
Brown Advisory
35
Brown Advisory
Maryland
$16.5M +$16.8M +945,738 New
Bank of New York Mellon
36
Bank of New York Mellon
New York
$14.6M +$14.8M +836,049 New
Northern Trust
37
Northern Trust
Illinois
$14.5M +$14.7M +831,120 New
Lazard Asset Management
38
Lazard Asset Management
New York
$13.8M +$14M +788,073 New
Norges Bank
39
Norges Bank
Norway
$13.4M +$13.6M +765,307 New
Geode Capital Management
40
Geode Capital Management
Massachusetts
$13M +$13.2M +745,341 New
TG
41
TCW Group
California
$11.7M +$11.8M +667,303 New
JP Morgan Chase
42
JP Morgan Chase
New York
$11.6M +$11.8M +663,422 New
Dimensional Fund Advisors
43
Dimensional Fund Advisors
Texas
$11.5M +$11.6M +655,103 New
ClearBridge Investments
44
ClearBridge Investments
New York
$10.7M +$10.8M +611,360 New
PCM
45
Palisade Capital Management
New Jersey
$10.4M +$10.5M +593,181 New
Morgan Stanley
46
Morgan Stanley
New York
$10.1M +$10.2M +578,005 New
IIM
47
Ironwood Investment Management
Massachusetts
$9.9M +$10M +565,956 New
Capital World Investors
48
Capital World Investors
California
$9.1M +$9.22M +520,000 New
Axa
49
Axa
France
$9.06M +$9.18M +517,822 New
Wells Fargo
50
Wells Fargo
California
$8.79M +$8.91M +502,737 New
1
2
3 4 5

ARIA Hedge Fund Activity: Q2 2013 in Review

198 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Ariad Pharmaceuticals Inc (ARIA) for Q2 2013, worth a combined $2.69B.

Buyers outnumbered sellers: 198 funds opened new ARIA positions and 0 closed out — a net gain of 198 holders — while 0 added to existing stakes and 0 trimmed.

  • 198 institutional investors held Ariad Pharmaceuticals Inc (ARIA) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $2.69B of Ariad Pharmaceuticals Inc stock for Q2 2013.
  • 198 funds opened new Ariad Pharmaceuticals Inc positions in Q2 2013 and 0 closed out, a net change of +198 holders.

Based on aggregated 13F filings for Q2 2013.